In addition, numerous recent studies have reported that CSCs in several types of cancer, such as leukemia, lung cancer, and colon cancer, exhibited overexpression of BCL-2 and BCL-XL that contributed to CSC survival [11, 21, 39]. This evidence concerns the gene BCL2L1 and lung carcinoma.